CompletedNCT05067244
MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD
This study is completed in Canada. It is testing MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD.
In CanadaPTSDBehavioralOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT01886469
A Phase II, Adaptive study Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
This study is completed in Canada. It focuses on ADHD.
In CanadaADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Enrolling By InvitationNCT07408934
A study of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia and schizoaffective disorder. Participants receive a study treatment and complete follow-up visits and assessments.
In CanadaSchizophreniaBehavioralOver 18 Years
CompletedNCT01141634
A study of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder
This study exists to see whether the medication Homeopathic is workable and worth testing more broadly. Researchers are trying to understand whether the medication Homeopathic can improve attention, thinking, or day-to-day functioning.
In CanadaADHDOtherFrom 6 Years to 16 Years
CompletedNCT02086864
A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD
This study exists to understand how the medication Homeopathic holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Homeopathic can improve attention, thinking, or day-to-day functioning.
In CanadaADHDBehavioralFrom 6 Years to 16 Years
CompletedNCT03033732
A Pragmatic Control study Comparing Models of Care in the Management of Prescription Opioid Misuse
This study is completed in Canada. It focuses on Addiction.
In CanadaAddictionDrugFrom 18 Years to 64 Years
CompletedNCT00885807
A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)
This summary needs review. Please check the official study record and contact the research team for details.
In CanadaADHDOtherOver 7 Years
CompletedNCT05604794
A Retrospective Effectiveness study of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
This summary needs review. Please check the official study record and contact the research team for details.
In CanadaPTSD, Depression, ...DrugOver 19 Years
TerminatedNCT02479906
A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for PTSD (PTSD)
This summary needs review. Please check the official study record and contact the research team for details.
In CanadaPTSDDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 68 Years
CompletedNCT02432703
Safety study of JNJ-42165279 in anxiety
This study is completed in the United States, in Australia, and in Canada. It is testing JNJ-42165279 for anxiety.
In CanadaAnxietyDrugFrom 18 Years to 64 Years
CompletedNCT05233085
A Safety Study of AZD4041 in Healthy Participants
This summary needs review. Please check the official study record and contact the research team for details.
In CanadaAddictionDrugFrom 18 Years to 55 Years
CompletedNCT05841030
A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
In CanadaDepressionOtherFrom 18 Years to 74 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.